Last edition
News about "Ozempic"
UK MHRA Updates Safety Information on Semaglutide Over Rare NAION Vision Risk
UK MHRA flags a very rare risk of NAION linked to semaglutide, urging patients to seek immediate medical attention for sudden changes in vision.
Ozempic | 07/02/2026 | By News Bureau | 487
Innovation Led Growth Dominates Indian Pharma Market in 2025
The India’s pharmaceutical market grew 10.6 percent year-on-year in December 2025, driven by chronic therapies, GLP-1 drugs, and strong innovation-led demand.
Ozempic | 15/01/2026 | By News Bureau | 694
Novo Nordisk to Launch Ozempic in India
The once-a-week injectable, Ozempic will complement Novo Nordisk’s existing oral Semaglutide for diabetes and recently approved WeGovy for obesity.
Ozempic | 30/09/2025 | By Dineshwori | 447
BioNxt Begins Lab-Scale ODF Development After Receiving Semaglutide API
BioNxt Solutions has received the Semaglutide active pharmaceutical ingredient (API), enabling the initiation of laboratory-scale formulation and testing of its oral dissolvable film (ODF) delivery system.
Ozempic | 03/09/2025 | By Dineshwori | 453
Novo Nordisk Reports 18% H1 Sales Growth, Lowers H2 Outlook for Wegovy and Ozempic
Novo Nordisk has announced its financial results for the first half of 2025, ending June 30, with sales rising 18 percent at constant exchange rates (CER) to DKK 154.9 billion (USD 24.78 billion).
Ozempic | 06/08/2025 | By Dineshwori | 1624
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy